Add firepower to your portfolio! 10 stocks which can turn multibaggers in 2-3 years

The market will give ample opportunities to retail investors to buy on dips as current valuations are unlikely to sustain without the support of bounce back in earnings growth.
If you have started investing in Indian stocks in January 2017, chances are you are sitting on huge pile of profits. The S&P BSE Sensex rallied nearly 20 percent and many small and midcap stocks gave multibagger returns in the same period.

In the spirit of Diwali, to start something new, retail investors should look to add more stocks to their portfolio which can deliver multibagger returns in the next 2-3 years.
Benchmark indices might not be able to deliver exceptional returns but individuals can double their wealth if they invest in the right stocks.


The market will give ample opportunities to retail investors to buy on dips as current valuations are unlikely to sustain without the support of bounce back in earnings growth.
The Sensex is currently trading at 18.8x of its FY2019 earnings which is an 8 percent premium to its 10-year average PE of 17.4x. Analysts suggest as interest rates are likely to remain lower, equities will stay attractive asset class and domestic inflows will be supportive of liquidity and valuations.

Investors’ can continue with their bottom-up stock picking approach and select stocks which can benefit from affordable housing scheme, consumption pick-up, banking, etc.

"The year 2017 has been a solid year for equities globally and India is no different. 2017 has also heralded an era of immense liquidity driven by the solid growth in domestic asset management industry. This liquidity has made parts of broader markets expensive with earnings not commensurate with the price action," Arbind Maheswari, Head of India Equities - Sales Trading, Bank of America Merrill Lynch told Moneycontrol.



"Also, visibility on earnings remains hazy for many of these overvalued names. Having said that, one can still find pockets of growth and visibility but the overall broader market remains expensive and in parts over-valued," he said.

For more information visit our site: www.capitalways.com


0 comments:

Top buy & sell ideas by Ashwani Gujral, Mitessh Thakkar, Prakash Gaba for short term

Mitessh Thakkar of mitesshthakkar.com suggests selling Aurobindo Pharma with a stop loss of Rs 731 for target of Rs 696 and Bank of Baroda...